臨床試驗成像市場：按產品/服務、方式、治療領域、最終用戶 - COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響 - 2023-2030 年全球預測

全球臨床試驗成像市場預計將大幅增長，2023年達到11.0753億美元，複合年增長率為7.11%，2030年達到17.9379億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球臨床試驗影像市場至關重要。 通過檢查業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場份額時的表現以及面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面信息。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細信息，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細信息。

4. 市場趨勢：全面了解 COVID-19、俄羅斯-烏克蘭衝突和高通脹的累積影響。

5.競爭評估和信息：對主要公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.臨床試驗成像的全球市場規模和預測是多少？

2. 在預測期內，COVID-19 對全球臨床試驗成像市場的抑制因素和影響是什麼？

3. 在預測期內，全球臨床試驗成像市場需要投資哪些產品/細分市場/應用/領域？

4. 你們在全球臨床試驗影像市場的競爭策略是什麼？

5.全球臨床試驗影像市場的技術趨勢和監管框架是什麼？

6.全球臨床試驗影像市場主要廠商的市場份額是多少？

7. 哪些形式和戰略舉措被認為適合進入全球臨床試驗成像市場？

目錄

第1章前言

第2章研究方法

第 3 章執行摘要

第4章市場概述

第 5 章市場洞察

• 市場動態
  • 驅動程序
    • 對藥物開發項目進行了大量投資
    • 顯著縮短藥物開發和審批時間
    • 在無法進行活檢時的非侵入性檢查方法和易用性
  • 抑制因素
    • 數據安全和隱私問題以及為研究而獲取的圖像的潛在濫用
  • 機會
    • 開發基於雲的平台以簡化圖像共享流程
    • 通過集成人工智能 (AI) 最大限度地減少錯誤並最大限度地提高效率
  • 作業
    • 與成像技術相關的高成本以及潛在的禁止輻射暴露
• 市場趨勢
• 新冠肺炎 (COVID-19) 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通脹的累積影響
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 監管框架
• 客戶定制

第 6 章臨床試驗影像市場（按產品和服務）

• 服務
  • 手術影像服務
  • 閱讀分析服務
  • 系統和技術支持服務
  • 試驗設計和諮詢服務
• 軟件

第七章按模式劃分的臨床試驗成像市場

• 計算機斷層掃描
• 超聲心動圖
• 磁共振成像
• 正電子發射斷層掃描
• 超聲波
• X射線

第 8 章按治療領域劃分的臨床試驗成像市場

• CVS
• 內分泌科
• 免疫性疾病
• 傳染病
• 神經病學
• 腫瘤學

第 9 章臨床試驗成像市場：按最終用戶劃分

• 學術和政府研究機構
• 生物技術公司
• 委託研究組織
• 醫療器械製造商
• 製藥公司

第10章美洲臨床試驗影像市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太地區臨床試驗影像市場

• 澳大利亞
• 中國
• 印度
• 印度尼西亞
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲臨床試驗影像市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 意大利
• 荷蘭
• 尼日利亞
• 挪威
• 波蘭
• 卡塔爾
• 俄羅斯
• 沙特阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合酋長國
• 英國

第13章競爭態勢

• FPNV定位矩陣
• 市場份額分析：按主要公司劃分
• 競爭情景分析：主要公司

第14章上市公司名單

第15章附錄

• 討論指南
• 關於許可證和價格

The Global Clinical Trial Imaging Market is forecasted to grow significantly, with a projected USD 1,107.53 million in 2023 at a CAGR of 7.11% and expected to reach a staggering USD 1,793.79 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Clinical Trial Imaging Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Clinical Trial Imaging Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product & Service, market is studied across Services and Software. The Services is further studied across Operational Imaging Services, Read Analysis Services, System & Technical Support Services, and Trial Design & Consulting Services. The Services is projected to witness significant market share during forecast period.

Based on Modality, market is studied across Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-Ray. The Computed Tomography is projected to witness significant market share during forecast period.

Based on Therapeutic area, market is studied across CVS, Endocrinology, Immunological Disorder, Infectious Diseases, Neurology, and Oncology. The Infectious Diseases is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology Companies, Contract Research Organizations, Medical Device Manufacturer, and Pharmaceutical Companies. The Contract Research Organizations is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Clinical Trial Imaging Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trial Imaging Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Imaging Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Imaging Market?

4. What is the competitive strategic window for opportunities in the Global Clinical Trial Imaging Market?

5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Imaging Market?

6. What is the market share of the leading vendors in the Global Clinical Trial Imaging Market?

7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Imaging Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Clinical Trial Imaging Market, by Product & Service, 2022 vs 2030
• 4.3. Clinical Trial Imaging Market, by Modality, 2022 vs 2030
• 4.4. Clinical Trial Imaging Market, by Therapeutic area, 2022 vs 2030
• 4.5. Clinical Trial Imaging Market, by End-User, 2022 vs 2030
• 4.6. Clinical Trial Imaging Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant investments made in drug development programs
    • 5.1.1.2. Significant reduction in the drug development and approval timelines
    • 5.1.1.3. A non-invasive method of study and usability when a biopsy is not possible
  • 5.1.2. Restraints
    • 5.1.2.1. Data security and privacy issues and possibility of misusing the images obtained for studies
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of cloud-based platform simplifying the process of image sharing
    • 5.1.3.2. Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
  • 5.1.4. Challenges
    • 5.1.4.1. High cost associated with the imaging techniques and potential exposure to prohibitive radiation
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Clinical Trial Imaging Market, by Product & Service

• 6.1. Introduction
• 6.2. Services
  • 6.2.1. Operational Imaging Services
  • 6.2.2. Read Analysis Services
  • 6.2.3. System & Technical Support Services
  • 6.2.4. Trial Design & Consulting Services
• 6.3. Software

7. Clinical Trial Imaging Market, by Modality

• 7.1. Introduction
• 7.2. Computed Tomography
• 7.3. Echocardiography
• 7.4. Magnetic Resonance Imaging
• 7.5. Positron Emission Tomography
• 7.6. Ultrasound
• 7.7. X-Ray

8. Clinical Trial Imaging Market, by Therapeutic area

• 8.1. Introduction
• 8.2. CVS
• 8.3. Endocrinology
• 8.4. Immunological Disorder
• 8.5. Infectious Diseases
• 8.6. Neurology
• 8.7. Oncology

9. Clinical Trial Imaging Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Government Research Institutes
• 9.3. Biotechnology Companies
• 9.4. Contract Research Organizations
• 9.5. Medical Device Manufacturer
• 9.6. Pharmaceutical Companies

10. Americas Clinical Trial Imaging Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Clinical Trial Imaging Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Trial Imaging Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. CLINICAL TRIAL IMAGING MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL TRIAL IMAGING MARKET SIZE, 2022 VS 2030
• FIGURE 3. CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
• FIGURE 5. CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2022 VS 2030 (%)
• FIGURE 6. CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
• FIGURE 7. CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. CLINICAL TRIAL IMAGING MARKET DYNAMICS
• FIGURE 10. CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CLINICAL TRIAL IMAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 5. CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CLINICAL TRIAL IMAGING MARKET SIZE, BY OPERATIONAL IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. CLINICAL TRIAL IMAGING MARKET SIZE, BY READ ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. CLINICAL TRIAL IMAGING MARKET SIZE, BY SYSTEM & TECHNICAL SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. CLINICAL TRIAL IMAGING MARKET SIZE, BY TRIAL DESIGN & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. CLINICAL TRIAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 13. CLINICAL TRIAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CLINICAL TRIAL IMAGING MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. CLINICAL TRIAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. CLINICAL TRIAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. CLINICAL TRIAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. CLINICAL TRIAL IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 20. CLINICAL TRIAL IMAGING MARKET SIZE, BY CVS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. CLINICAL TRIAL IMAGING MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. CLINICAL TRIAL IMAGING MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. CLINICAL TRIAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. CLINICAL TRIAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. CLINICAL TRIAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CLINICAL TRIAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. CLINICAL TRIAL IMAGING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. CLINICAL TRIAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. CLINICAL TRIAL IMAGING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. CLINICAL TRIAL IMAGING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 52. CANADA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 76. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 77. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 81. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 82. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 83. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 167. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 168. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 169. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 170. ITALY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 187. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 188. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 189. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 190. POLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 192. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 193. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 194. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 195. QATAR CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 242. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 243. CLINICAL TRIAL IMAGING MARKET LICENSE & PRICING